Pharmacy
News
Antibody gets orphan status for CTCL in Europe
IPH4102 is a cytotoxic anti-KIR3DL2 monoclonal antibody (mAb) that targets CTCL cells. Orphan status provides Innate Pharma, the company...
News
FDA approves generic decitabine for MDS
Credit: Bill Branson The US Food and Drug Administration (FDA) has approved decitabine for injection, a generic version of Dacogen, to treat...
News
Drug granted orphan status for PNH in EU
A novel compound has received orphan status in the Europe Union to treat paroxysmal nocturnal hemoglobinuria (PNH), a life-threatening disease...
News
FDA approves eltrombopag for SAA
Eltrombopag is an oral thrombopoietin receptor agonist that helps to induce the proliferation and differentiation of hematopoietic stem cells to...
News
Enrollment terminated in anticoagulant trial
Credit: Andre E.X.
News
Product prevents bleeding in hemophilia A, company says
A recombinant factor VIII (rFVIII) product known as BAX 855 can prevent bleeding in hemophilia A patients, according to Baxter International, the...
News
Path to drug development often not straightforward, study shows
Credit: Rhoda Baer An analysis of university discoveries licensed to biotechnology firms has revealed early bottlenecks in the drug development...
News
FDA expands indication for apixaban
Credit: Kevin MacKenzie The US Food and Drug Administration (FDA) has approved apixaban (Eliquis) to treat venous thromboembolism (VTE) and...
News
Rise of new anticoagulants means higher costs
Credit: CDC A new study suggests the use of novel oral anticoagulants (NOACs) has surpassed warfarin use in the last few years, but the cost...
News
NICE supports lenalidomide for MDS
The UK’s National Institute for Health and Care Excellence (NICE) has issued a final draft guidance recommending lenalidomide (Revlimid) as an...
News
DOJ closes investigation of PLATO trial
Credit: AstraZeneca The US Department of Justice (DOJ) is closing its investigation of PLATO, a clinical trial of the antiplatelet agent...